Retatrutide: What We Know So Far About the "Triple Agonist" Still Under Study
Retatrutide acts on three different hormone receptors and has generated excitement in the medical community. Learn what is currently known about this molecule still in the research phase.
Wegovy vs Mounjaro: Which Has More Evidence for Weight Loss?
Wegovy and Mounjaro are two leading approved options for weight loss. Here’s what studies directly comparing these treatments reveal.
Mounjaro vs Ozempic: Differences in Mechanism, Effectiveness, and Side Effects
A direct comparison between tirzepatide (Mounjaro) and semaglutide (Ozempic): mechanism of action, results observed in studies, and differences in side effect profiles.
Wegovy: Semaglutide Specifically Developed for Weight Loss
Learn about Wegovy, the higher-dose semaglutide version approved specifically for obesity treatment, and understand how it differs from other formulations.
Ozempic (Semaglutide): From Diabetes Treatment to Weight Loss Popularity
Learn how semaglutide, the active ingredient in Ozempic, was developed for type 2 diabetes and why it became widely associated with weight loss.
Mounjaro (Tirzepatide): How It Works and Who It’s For
Learn how tirzepatide, the active ingredient in Mounjaro, works in the body through a dual mechanism and which patient profiles typically benefit from this treatment.
GLP-1 and Physical Exercise: Enhancing Treatment Outcomes
Physical activity is a key component during GLP-1 treatment, helping preserve muscle mass and boost results. Learn how to combine these two strategies effectively.
GLP-1 Combined with Other Molecules: What Science Says About These Combinations
Researchers are studying the combination of GLP-1 agonists with other molecules to enhance outcomes or preserve muscle mass. Learn what is currently known about these combinations.